https://pharmadog.xyz/news/658839 pharmadog en 2026-11-09T12:55:07.000Z Trump administration issues new guidelines to curb AI-driven bioweapon threats https://pharmadog.xyz/news/658627 pharmadog en 2026-11-09T11:23:25.000Z Argenx to acquire macrocycle biotech Unnatural Products in up to $1.15 billion deal https://pharmadog.xyz/news/658415 pharmadog en 2026-11-09T10:00:00.000Z State incentives can shape site decisions for commercial-stage life sciences firms https://pharmadog.xyz/news/658416 pharmadog en 2026-11-09T10:00:00.000Z Phase II success does not guarantee easy Phase III launch, says Thermo Fisher https://pharmadog.xyz/news/658417 pharmadog en 2026-11-09T10:00:00.000Z Early technical expertise key to tackling complex life-science construction projects https://pharmadog.xyz/news/658229 pharmadog en 2026-11-09T09:30:00.000Z Democrats weigh limits of health-care reforms after midterm win https://pharmadog.xyz/news/658230 pharmadog en 2026-11-09T09:30:00.000Z AI chatbots may help men share emotions, study suggests https://pharmadog.xyz/news/658228 pharmadog en 2026-11-09T09:30:00.000Z Global liver experts agree on definition of acute-on-chronic liver failure https://pharmadog.xyz/news/658227 pharmadog en 2026-11-09T09:30:00.000Z CVS split into two entities fails to address core issues in pharmacy benefit management https://pharmadog.xyz/news/657535 pharmadog en 2026-11-09T05:08:00.000Z AbbVie and BMS each secure FDA approval, but impact of their neuro‑drug acquisitions remains uncertain https://pharmadog.xyz/news/657536 pharmadog en 2026-11-09T05:02:00.000Z FDA launches Rare Disease Framework to embed patient input early in drug development https://pharmadog.xyz/news/657537 pharmadog en 2026-11-09T05:01:00.000Z Gene therapy sponsors urged to address six GMP manufacturing considerations early https://pharmadog.xyz/news/658602 pharmadog en 2026-11-09T04:56:00.000Z Vir Biotechnology's Phase 3 Trial Shows Primary Endpoint Success in Chronic Hepatitis Delta https://pharmadog.xyz/news/658158 pharmadog en 2026-11-09T04:12:00.000Z Valneva's Shigella vaccine cuts infection rates in phase 2 trial https://pharmadog.xyz/news/658159 pharmadog en 2026-11-09T03:19:00.000Z Argenx acquires Unnatural Products for up to $1.15 billion to boost oral peptide platform https://pharmadog.xyz/news/656331 pharmadog en 2026-11-08T22:15:00.000Z Study finds training bystanders and responders does not boost survival after sudden cardiac arrest https://pharmadog.xyz/news/655971 pharmadog en 2026-11-08T21:15:33.000Z Vir Biotechnology reports positive results for hepatitis D combo in first pivotal trial https://pharmadog.xyz/news/653843 pharmadog en 2026-11-08T09:30:00.000Z Recent heart-drug trials miss endpoints, raising doubts about AI-driven drug design https://pharmadog.xyz/news/658918 pharmadog en 2026-11-08T05:00:00.000Z Fresh & Ready Foods recalls 2,414 Fresh To You sausage, egg & cheese biscuit sandwiches over possible Listeria contamination https://pharmadog.xyz/news/651503 pharmadog en 2026-11-07T21:39:02.000Z New studies highlight hurdles in lowering blood pressure after stroke or in diabetes patients https://pharmadog.xyz/news/651459 pharmadog en 2026-11-07T21:12:08.000Z FDA opens investigation into Novartis' Zolgensma after cancer cases reported https://pharmadog.xyz/news/650575 pharmadog en 2026-11-07T16:57:13.000Z Biotech Trade Group BIO Sues Over Medicare GLOBE Pricing Pilot https://pharmadog.xyz/news/650215 pharmadog en 2026-11-07T14:50:59.000Z Novo and Novartis see heart drug setbacks as trials show minimal efficacy https://pharmadog.xyz/news/650407 pharmadog en 2026-11-07T14:50:00.000Z STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy https://pharmadog.xyz/news/650408 pharmadog en 2026-11-07T14:35:00.000Z Novo Nordisk’s anti-inflammatory drug ziltivekimab fails to cut heart events, but cardiologists still eye inflammation pathway